Search research articles
Contact Us
Filters
Showing results (271-280 of 308) with videos related to
Page
of 31
Sort By:
The Journal of Biological Chemistry
|
September 22, 2016
A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses
Bai Liu, Lin Kong, Kaiping Han, et al.
Journal for Immunotherapy of Cancer
|
August 25, 2025
Constructing the cure: engineering the next wave of antibody and cellular immune therapies
Stefanie R Bailey, Eric Bartee, Kyle G Daniels, et al.
JCI Insight
|
April 20, 2017
β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activity
Kinga Majchrzak, Michelle H Nelson, Jacob S Bowers, et al.
Science Immunology
|
August 2, 2017
Platelets subvert T cell immunity against cancer via GARP-TGFβ axis
Saleh Rachidi, Alessandra Metelli, Brian Riesenberg, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 27, 2021
Impaired Neutralizing Antibody Response to COVID-19 mRNA Vaccines in Cancer Patients
Cong Zeng, John P Evans, Sarah Reisinger, et al.
The Journal of Clinical Investigation
|
May 24, 2024
Spatial and functional targeting of intratumoral Tregs reverses CD8+ T cell exhaustion and promotes cancer immunotherapy
Lei Zhou, Maria Velegraki, Yi Wang, et al.
Cell & Bioscience
|
November 22, 2021
Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients
Cong Zeng, John P Evans, Sarah Reisinger, et al.
Breast Cancer Research : BCR
|
November 7, 2024
The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancer
Jasmine M Manouchehri, Jharna Datta, Lynn M Marcho, et al.
Cancer Gene Therapy
|
July 18, 2015
IL-12 conditioning improves retrovirally mediated transduction efficiency of CD8+ T cells
K Andrijauskaite, S Suriano, C A Cloud, et al.
Cancer Research
|
April 12, 2018
Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8<sup>+</sup> T Cells
C Bryce Johnson, Bennett R May, Brian P Riesenberg, et al.
Page
of 31
Search research articles
Search
Showing results (271-280 of 308) with videos related to
Sort By:
Page
of 31
The Journal of Biological Chemistry
|
September 22, 2016
A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses
Bai Liu, Lin Kong, Kaiping Han, et al.
Journal for Immunotherapy of Cancer
|
August 25, 2025
Constructing the cure: engineering the next wave of antibody and cellular immune therapies
Stefanie R Bailey, Eric Bartee, Kyle G Daniels, et al.
JCI Insight
|
April 20, 2017
β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activity
Kinga Majchrzak, Michelle H Nelson, Jacob S Bowers, et al.
Science Immunology
|
August 2, 2017
Platelets subvert T cell immunity against cancer via GARP-TGFβ axis
Saleh Rachidi, Alessandra Metelli, Brian Riesenberg, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 27, 2021
Impaired Neutralizing Antibody Response to COVID-19 mRNA Vaccines in Cancer Patients
Cong Zeng, John P Evans, Sarah Reisinger, et al.
The Journal of Clinical Investigation
|
May 24, 2024
Spatial and functional targeting of intratumoral Tregs reverses CD8+ T cell exhaustion and promotes cancer immunotherapy
Lei Zhou, Maria Velegraki, Yi Wang, et al.
Cell & Bioscience
|
November 22, 2021
Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients
Cong Zeng, John P Evans, Sarah Reisinger, et al.
Breast Cancer Research : BCR
|
November 7, 2024
The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancer
Jasmine M Manouchehri, Jharna Datta, Lynn M Marcho, et al.
Cancer Gene Therapy
|
July 18, 2015
IL-12 conditioning improves retrovirally mediated transduction efficiency of CD8+ T cells
K Andrijauskaite, S Suriano, C A Cloud, et al.
Cancer Research
|
April 12, 2018
Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8<sup>+</sup> T Cells
C Bryce Johnson, Bennett R May, Brian P Riesenberg, et al.
Page
of 31